Switch to:

Key Ratios

New Key Statistics Module, Z-Score and F-Score
Market Cap $M35.6Revenue $M5.1Net Margin (%)25.3Altman Z-Score5.5
Enterprise Value $M34.5EPS $0.0Operating Margin %27.2Piotroski F-Score4
P/E(ttm)28.0Beneish M-Score2.2Pre-tax Margin (%)25.3Higher ROA y-yY
Price/Book6.410-y EBITDA Growth Rate %--Quick Ratio2.4Cash flow > EarningsN
Price/Sales7.35-y EBITDA Growth Rate %--Current Ratio2.4Lower Leverage y-yN
Price/Free Cash Flow--y-y EBITDA Growth Rate %--ROA % (ttm)19.2Higher Current Ratio y-yN
Dividend Yield %--PEG--ROE % (ttm)27.2Less Shares Outstanding y-yN
Payout Ratio %--Shares Outstanding M63.6ROIC % (ttm)65.0Gross Margin Increase y-yN

Gurus Latest Trades with IGXT

Number of guru portfolios checked: 68.
No Entry found in the selected group of Gurus. You can

IGXT is held by these investors:

No Entry found in the selected group of Gurus. You can
Premium Most recent portfolio changes are included for Premium Members only!


IGXT: Insider Buys/Sells

Click Here for All Insider Trades.
InsiderPosition Date Trades Shares Trade Price ($) Change (%) Details
Boudreau BernardDirector 2016-01-22Buy65,000$0.4914.29view
Bechard Robert J.VP Corporate Development 2016-01-22Buy10,000$0.512view
Godin AndreEVP + CFO 2016-01-20Buy20,000$0.440view
Godin AndreEVP & CFO 2015-12-30Buy9,500$0.527.69view
Godin AndreEVP + CFO 2015-12-23Buy15,350$0.519.8view
Godin AndreEVP + CFO 2015-12-22Buy19,650$0.512view
Zerbe IngridCorporate Secretary 2015-08-25Sell163,100$0.512view
Zerbe Horst GCEO 2015-08-25Sell36,900$0.512view
Zerbe IngridCorporate Secretary 2015-04-20Sell66,900$0.66-15.15view
Zerbe Horst GCEO 2015-04-17Sell60,000$0.66-15.15view

Press Releases about IGXT :

Quarterly/Annual Reports about IGXT:

News about IGXT:

Articles On GuruFocus.com
No related article found.

More From Other Websites
IntelGenx Technologies Corp. :IGXT-US: Earnings Analysis: 2015 By the Numbers Apr 12 2016
INTELGENX TECHNOLOGIES CORP. Financials Apr 02 2016
INTELGENX TECHNOLOGIES CORP. Files SEC form 10-K, Annual Report Mar 30 2016
IntelGenx and RedHill Biopharma Announce RIZAPORT(TM) Commercialization Term Sheet With Grupo Juste... Mar 29 2016
INTELGENX TECHNOLOGIES CORP. Files SEC form 8-K, Other Events Mar 29 2016
RedHill Biopharma and IntelGenx Announce RIZAPORT™ Commercialization Term Sheet with Grupo JUSTE... Mar 29 2016
IntelGenx and RedHill Biopharma Announce RIZAPORT(TM) Commercialization Term Sheet With Grupo Juste... Mar 29 2016
IntelGenx Announces Development and Commercialization Term Sheet with a Global Pharmaceutical... Mar 24 2016
INTELGENX TECHNOLOGIES CORP. Files SEC form 8-K, Other Events Mar 24 2016
IntelGenx Announces Development and Commercialization Term Sheet with a Global Pharmaceutical... Mar 24 2016
INTELGENX TECHNOLOGIES CORP. Files SEC form 8-K, Results of Operations and Financial Condition Mar 22 2016
IntelGenx Reports Record 2015 Financial Results Mar 22 2016
IntelGenx Reports Record 2015 Financial Results Mar 22 2016
IntelGenx to Host Conference Call and Webcast of Fourth Quarter and Full-Year 2015 Financial Results... Mar 09 2016
IntelGenx Appoints Dr. Dana Matzen as Vice President, Business Development Mar 02 2016
INTELGENX TECHNOLOGIES CORP. Files SEC form 8-K, Other Events Mar 02 2016
RedHill Biopharma Announces Notice of Allowance for U.S. Patent Covering RIZAPORT™ for Migraines Feb 18 2016
IntelGenx Announces USPTO Has Granted Patent Protecting RIZAPORT(TM) Oral Film for Migraines Feb 18 2016
IntelGenx Files Loxapine Oral Film Patent for Schizophrenia Feb 10 2016
IntelGenx Announces Creation of a Scientific Advisory Board Feb 04 2016

Add Notes, Comments

If you want to ask a question or report a bug, please create a support ticket.
Get WordPress Plugins for easy affiliate links on Stock Tickers and Guru Names | Earn affiliate commissions by embedding GuruFocus Charts
GuruFocus Affiliate Program: Earn up to $400 per referral. ( Learn More)